Brainstorm Financial Statements From 2010 to 2025

BCLI Stock  USD 1.58  0.04  2.60%   
Brainstorm Cell financial statements provide useful quarterly and yearly information to potential Brainstorm Cell Therapeutics investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on Brainstorm Cell financial statements helps investors assess Brainstorm Cell's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Brainstorm Cell's valuation are summarized below:
Market Capitalization
9.1 M
Earnings Share
(3.45)
We have found one hundred twenty available fundamental signals for Brainstorm Cell Therapeutics, which can be analyzed and compared to other ratios and to its rivals. Traders should compare all of Brainstorm Cell Therapeutics prevailing fundamentals against the fundamentals between 2010 and 2025 to make sure the company is sustainable this year. The current Market Cap is estimated to decrease to about 150.7 M. Enterprise Value is estimated to decrease to about 150.1 M

Brainstorm Cell Total Revenue

(366,000)

Check Brainstorm Cell financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Brainstorm Cell's main balance sheet or income statement drivers, such as Depreciation And Amortization of 304.4 K, Interest Expense of 515 K or Selling General Administrative of 12.9 M, as well as many indicators such as Dividend Yield of 0.0, Invested Capital of 0.0 or Average Payables of 380.1 K. Brainstorm financial statements analysis is a perfect complement when working with Brainstorm Cell Valuation or Volatility modules.
  
Check out the analysis of Brainstorm Cell Correlation against competitors.

Brainstorm Cell Balance Sheet

Current ValueLast YearHistorical Average 10 Year Trend
Total Assets8.6 M4.8 M11.6 M
Pretty Stable
Short and Long Term Debt Total734.2 K772.8 K2.5 M
Pretty Stable
Other Current Liabilities3.4 M3.3 M1.3 M
Slightly volatile
Total Current Liabilities9.4 MM5.8 M
Slightly volatile
Cash1.4 M1.5 M4.9 M
Pretty Stable
Non Current Assets Total1.6 M2.7 M2.1 M
Slightly volatile
Cash And Short Term Investments1.4 M1.5 M8.2 M
Pretty Stable
Common Stock Total Equity14.5 K13.8 K10.3 K
Slightly volatile
Common Stock Shares Outstanding52 M49.5 M24.3 M
Slightly volatile
Liabilities And Stockholders Equity8.6 M4.8 M11.6 M
Pretty Stable
Non Current Liabilities Total1.3 M1.5 M1.8 M
Slightly volatile
Other Current Assets661.7 K630.2 K448 K
Slightly volatile
Other Stockholder Equity253.7 M241.7 M122.6 M
Slightly volatile
Total Liabilities10.9 M10.4 M6.9 M
Slightly volatile
Total Current Assets2.1 M2.2 M9.2 M
Pretty Stable
Short Term Debt1.1 M693.5 K1.4 M
Pretty Stable
Common Stock7.5 K14.9 K10 K
Slightly volatile
Property Plant And Equipment Net1.6 M2.4 MM
Slightly volatile
Property Plant And Equipment Gross6.4 M6.1 M2.8 M
Slightly volatile
Accounts PayableM5.7 M3.7 M
Slightly volatile
Net Receivables55.7 K58.6 K613 K
Pretty Stable
Other Liabilities266.9 K141.4 K170.5 K
Pretty Stable
Property Plant Equipment6.4 M6.1 M2.7 M
Slightly volatile
Capital Surpluse233 M221.9 M121.4 M
Slightly volatile
Long Term Investments17.1 K18 K33.2 K
Slightly volatile
Non Current Liabilities Other4.4 M4.2 M1.9 M
Slightly volatile
Capital Stock12.8 K13.8 K11.5 K
Slightly volatile
Capital Lease Obligations5.2 M4.7 M3.4 M
Slightly volatile

Brainstorm Cell Income Statement

Current ValueLast YearHistorical Average 10 Year Trend
Selling General Administrative12.9 M12.3 MM
Slightly volatile
Other Operating Expenses25.9 M24.7 M14.3 M
Slightly volatile
Total Operating Expenses25.6 M24.4 M14.2 M
Slightly volatile
Research Development7.1 M12.1 M8.9 M
Slightly volatile
Selling And Marketing Expenses6.6 M12.3 M9.9 M
Pretty Stable
Interest Income658.1 K626.8 K208.9 K
Slightly volatile
Reconciled Depreciation218.7 K309.4 K157.2 K
Slightly volatile

Brainstorm Cell Cash Flow Statement

Current ValueLast YearHistorical Average 10 Year Trend
Begin Period Cash Flow843.4 K887.8 K4.7 M
Slightly volatile
Depreciation231.9 K238.5 K149.6 K
Slightly volatile
End Period Cash Flow1.6 K1.7 K4.6 M
Pretty Stable
Stock Based Compensation1.6 K1.7 K880.1 K
Pretty Stable
Change To Netincome1.4 M1.9 M1.3 M
Slightly volatile
Issuance Of Capital Stock13.7 M14.3 M8.3 M
Slightly volatile

Financial Ratios

Current ValueLast YearHistorical Average 10 Year Trend
Average Payables380.1 K581.3 K603.9 K
Very volatile
Capex To Depreciation0.07420.078136.8821
Slightly volatile
Payables Turnover0.05840.061532.0606
Slightly volatile
Cash Per Share0.02590.02720.3766
Pretty Stable
Days Payables Outstanding6.2 K6.1 K7.1 K
Slightly volatile
Income Quality1.121.070.8297
Slightly volatile
Intangibles To Total Assets8.0E-48.0E-40.0264
Slightly volatile
Current Ratio0.210.222.8657
Slightly volatile
Graham Number1.11.161.9956
Very volatile
Capex Per Share5.0E-45.0E-40.019
Slightly volatile
Average Receivables32.2 K55.9 K57.1 K
Very volatile
Interest Debt Per Share0.01710.0180.0895
Very volatile
Debt To Assets0.170.180.2954
Slightly volatile
Days Of Payables Outstanding6.2 K6.1 K7.1 K
Slightly volatile
Ebt Per Ebit1.140.921.0334
Slightly volatile
Quick Ratio0.210.222.8657
Slightly volatile
Net Income Per E B T0.780.880.9609
Pretty Stable
Cash Ratio0.180.191.1486
Slightly volatile
Free Cash Flow Operating Cash Flow Ratio0.00110.00120.8532
Slightly volatile
Debt Ratio0.170.180.2954
Slightly volatile
Gross Profit Margin0.210.160.1481
Very volatile

Brainstorm Cell Valuation Data

Current ValueLast YearHistorical Average 10 Year Trend
Market Cap150.7 M158.6 M631.7 M
Very volatile
Enterprise Value150.1 M158 M628.8 M
Very volatile

Brainstorm Fundamental Market Drivers

Cash And Short Term Investments1.3 M

Brainstorm Upcoming Events

4th of April 2024
Upcoming Quarterly Report
View
20th of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
4th of April 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

About Brainstorm Cell Financial Statements

Investors use fundamental indicators, such as Brainstorm Cell's revenue or net income, to determine how well the company is positioned to perform in the future. Although Brainstorm Cell's investors may analyze each financial statement separately, they are all interrelated. Understanding these patterns can help investors make the right trading decisions.
Last ReportedProjected for Next Year
Current Deferred Revenue-693.5 K-658.8 K
Cost Of Revenue304.8 K320 K
Stock Based Compensation To Revenue(1.88)(1.97)
Sales General And Administrative To Revenue(18.21)(17.30)
Research And Ddevelopement To Revenue(42.30)(44.42)
Capex To Revenue(1.16)(1.22)
Revenue Per Share(0.02)(0.02)
Ebit Per Revenue 56.56  59.39 

Currently Active Assets on Macroaxis

When determining whether Brainstorm Cell Ther offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Brainstorm Cell's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Brainstorm Cell Therapeutics Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Brainstorm Cell Therapeutics Stock:
Check out the analysis of Brainstorm Cell Correlation against competitors.
You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Brainstorm Cell. If investors know Brainstorm will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Brainstorm Cell listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(3.45)
Return On Assets
(2.16)
Return On Equity
(11.22)
The market value of Brainstorm Cell Ther is measured differently than its book value, which is the value of Brainstorm that is recorded on the company's balance sheet. Investors also form their own opinion of Brainstorm Cell's value that differs from its market value or its book value, called intrinsic value, which is Brainstorm Cell's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Brainstorm Cell's market value can be influenced by many factors that don't directly affect Brainstorm Cell's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Brainstorm Cell's value and its price as these two are different measures arrived at by different means. Investors typically determine if Brainstorm Cell is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Brainstorm Cell's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.